Cargando…

Eligibility, uptake and response to germline genetic testing in women with DCIS

BACKGROUND: Ductal carcinoma in situ (DCIS) is a malignant, yet pre-invasive disease of the breast. While the majority of DCIS have low risk of recurrence, a subset of women with germline pathogenic variants (PV) in cancer predisposition genes are at increased risk for recurrence. Uptake of genetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turza, Lauren, Lovejoy, Leann A., Turner, Clesson E., Shriver, Craig D., Ellsworth, Rachel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459377/ https://www.ncbi.nlm.nih.gov/pubmed/36091166 http://dx.doi.org/10.3389/fonc.2022.918757

Ejemplares similares

Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
por: Lovejoy, Leann A., et al.
Publicado: (2020)

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
por: Rummel, Seth K., et al.
Publicado: (2020)

Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness
por: Lovejoy, Leann A, et al.
Publicado: (2021)

Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer
por: Lovejoy, Leann A., et al.
Publicado: (2023)

Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System
por: Darmon, Sarah, et al.
Publicado: (2023)

Management of Incidental Findings in the Era of Next-generation Sequencing
por: Blackburn, Heather L., et al.
Publicado: (2015)

Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients
por: Darmon, Sarah, et al.
Publicado: (2022)

A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements
por: Ellsworth, Darrell L., et al.
Publicado: (2019)

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making
por: Shelton, Charles, et al.
Publicado: (2023)

Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast
por: Valente, Allyson L, et al.
Publicado: (2014)

Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) Score
por: Lalani, Nafisha, et al.
Publicado: (2017)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
por: Yu, Li-Na, et al.
Publicado: (2019)

Association of the 12-Gene Breast DCIS Score(®) Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols
por: Leonard, Charles E., et al.
Publicado: (2021)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

PSPHL and breast cancer in African American women: causative gene or population stratification?
por: Rummel, Seth, et al.
Publicado: (2014)

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer
por: Ward, William H., et al.
Publicado: (2019)

Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma Germline mutations in Ewing sarcoma
por: Brohl, Andrew S, et al.
Publicado: (2017)

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ
por: Manders, Jennifer B., et al.
Publicado: (2016)

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
por: Sturtz, Lori A, et al.
Publicado: (2014)

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
por: Ramsey, Mitchell L., et al.
Publicado: (2022)

A medicare-based comparative mortality analysis of active surveillance in older women with DCIS
por: Akushevich, Igor, et al.
Publicado: (2020)

Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study
por: Rummel, Seth, et al.
Publicado: (2012)

Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes
por: Shriver, Craig D, et al.
Publicado: (2014)

Genomic Heterogeneity of Breast Tumor Pathogenesis
por: Ellsworth, Rachel E., et al.
Publicado: (2009)

Breast Cancer in the Personal Genomics Era
por: Ellsworth, Rachel E., et al.
Publicado: (2010)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
por: Bobin, Arthur, et al.
Publicado: (2020)

Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies
por: Godley, Lucy A.
Publicado: (2023)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients
por: Culver, Julie O., et al.
Publicado: (2022)

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients
por: Toro, Allyson L., et al.
Publicado: (2016)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Imaging features of noncalcified DCIS
por: Scudder, JM, et al.
Publicado: (2012)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes
por: Schwartz, Alison, et al.
Publicado: (2022)

Low-risk DCIS. What is it? Observe or excise?
por: Pinder, Sarah E., et al.
Publicado: (2021)

Common genetic susceptibility to DCIS and invasive ductal carcinoma
por: Sopik, Victoria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b8cmjr6g6sjg3vfovdci3fe26d